Improving access and use of psychotropic medicines.
Publication details: Geneva : World Health Organization, 2005. Description: xi, 57 p. : ill. ; 29 cmISBN: 9241546417Subject(s): Psychotropic drugs | Essential drugs | Mental disorders | Drug utilization | Drug costs | Drug and narcotic control | GuidelinesNLM classification: QV 77.2 I 2005Summary: The objective of this document is to provide guidance to risk assessors on the use of quantitative toxicokinetic and toxicodynamic data to address interspecies and interindividual differences in dose/concentration-response assessment. Section 1 focuses on the relevance of this guidance in the context of the broader risk assessment paradigm and other initiatives of the International Program on Chemical Safety (IPCS) project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals. Technical background material is presented in section 2, followed by generic guidance for the development of chemical-specific adjustment factors in section 3 and accompanying summary figures. Illustrative case-studies are included in an Appendix and a glossary of terms is also provided.Item type | Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
Books | FNPH LIBRARY | QV 77.2 I 2005 (Browse shelf(Opens below)) | Available | 03565 |
Browsing FNPH LIBRARY shelves Close shelf browser (Hides shelf browser)
No cover image available | ||||||||
QV 766 W 2002 WHO monographs on selected medicinal plants. | QV 766 W 2007 WHO monographs on selected medicinal plants. | QV 766 W 2009 WHO monographs on selected medicinal plants. | QV 77.2 I 2005 Improving access and use of psychotropic medicines. | QV 77.2 I 2005 Menatl health policy and service guidance package : | QV 77.2 P 2009 Pharmacological treatment of mental disorders in primary health care. | QV 77.2 P 2009 Pharmacological treatment of mental disorders in primary health care. |
The objective of this document is to provide guidance to risk assessors on the use of quantitative toxicokinetic and toxicodynamic data to address interspecies and interindividual differences in dose/concentration-response assessment. Section 1 focuses on the relevance of this guidance in the context of the broader risk assessment paradigm and other initiatives of the International Program on Chemical Safety (IPCS) project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals. Technical background material is presented in section 2, followed by generic guidance for the development of chemical-specific adjustment factors in section 3 and accompanying summary figures. Illustrative case-studies are included in an Appendix and a glossary of terms is also provided.
There are no comments on this title.